Address
Email address
https://jmolner.comThe J. Molner Company | Get Chemistry Done! | Analytical ChemsitryAmplify your generic drug pipeline with the J. Molner Company | Contract injectable development for the US, Canada, and Europe | Analytical Chemistry Services | Commerical and R&D stability services with our Nordic Stability Service team.
Name
J.Molner AS
Registry code
16579077
Type
AS - Joint Stock Company
Status
Registered
Foundation date
22.09.2022 (3)
Financial year
01.01-31.12
Capital
1 686 001.00 €
Activity
70201 -
-
-82 193 €
-
-
2 104 719 €
-
Submitted
No tax arrears
-4%
-2%
| Owner | Representative | Beneficial owner | |
|---|---|---|---|
| Jason Michael Atticus Grenfell-Gardner
| - | Board member | - |
| Omanikukonto: ANTTI OLAVI ROSLAKKA
| 95% - 1 600 000.00 EUR | - | - |
| Owner | Representative | Beneficial owner | |
|---|---|---|---|
| The J. Molner Company OÜ 16049586 | 100% - 2 500.00 EUR | - | - |
| Nordisk Element OÜ 17251775 | 100% - 0.01 EUR | - | - |
| 2022 25.04.2023 | 2023 27.06.2024 | 2024 10.06.2025 | |
|---|---|---|---|
| Total Revenue | - | - | - |
| Net profit (loss) for the period | -143 268 € | -30 203 € | -82 193 € |
| Profit Margin | - | - | - |
| Current Assets | 644 534 € | 3 457 € | 6 497 € |
| Fixed Assets | 1 600 000 € | 4 010 914 € | 3 630 616 € |
| Total Assets | 2 244 534 € | 4 014 371 € | 3 637 113 € |
| Current Liabilities | 89 474 € | 1 187 € | 72 298 € |
| Non Current Liabilities | - | 1 866 616 € | 1 460 096 € |
| Total Liabilities | - | 1 867 803 € | 1 532 394 € |
| Share Capital | 1 686 001 € | 1 686 001 € | 1 686 001 € |
| Equity | 2 155 060 € | 2 146 568 € | 2 104 719 € |
| Employees | 0 | - | - |
